Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Psycliomotor and Cognitive Residual Effects After Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopielone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Plurazepam 30 mg As An External Comparator

NCT00283790 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00283790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Psycliomotor and Cognitive Residual Effects After Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopielone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Plurazepam 30 mg As An External Comparator
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
April 30, 2006
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia